Breast Cancer Clinical Trial
Official title:
Finding the M.I.N.C. for Mammography Maintenance
RATIONALE: Mammography reminders may encourage women to undergo regular mammography
screenings for breast cancer.
PURPOSE: This randomized clinical trial is studying three different mammography reminder
interventions to compare how well they work in encouraging women to undergo regular
mammography screenings for breast cancer.
OBJECTIVES:
- Compare the effectiveness of mammography reminder interventions using usual care
reminder vs enhanced automated phone reminder vs enhanced letter reminder in increasing
the proportion of women who undergo annual mammograms as recommended by medical
organizations.
- Compare the impact of alternative delivery channels (mail vs automated phone reminders)
and enhanced messages in facilitating maintenance of mammography in these participants.
- Determine the incremental benefit of adding a consequence elaboration component to
barriers-specific telephone counseling in encouraging these participants to regain
adherence to mammography.
- Determine the minimum intervention needed for change to ensure annual mammography and
maintenance in participants.
OUTLINE: This is a randomized, controlled study. Participants are randomized to 1 of 3 arms.
- Arm I: Participants receive a usual care mammography reminder by telephone annually for
4 years.
- Arm II: Participants receive an enhanced automated phone mammography reminder annually
for 4 years.
- Arm III: Participants receive an enhanced letter mammography reminder annually for 4
years.
Insurance claims reports and patients' self reports as to whether or not they subsequently
underwent mammography are examined. Patients who do not undergo mammography within 6 months
after receiving a reminder are further randomized to 1 of 4 arms.
- Arm I: Participants receive no further reminders until the next annual reminder.
- Arm II: Participants receive an enhanced Barriers-Specific Counseling Call
(BarriConCall) annually for 4 years that focuses on positive consequences of undergoing
mammography.
- Arm III: Participants receive an enhanced BarriConCall annually for 4 years that
focuses on negative consequences of not undergoing mammography.
- Arm IV: Participants receive a standard barrier call (BarriCall) annually for 4 years.
PROJECTED ACCRUAL: A total of 4,040 participants (1,000 for usual care mammography reminder;
1,520 for enhanced automated phone mammography reminder; and 1,520 for enhanced letter
mammography reminder) will be accrued for this study.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |